Cases 1 - 10 of 55
Galderma Laboratories, L.P. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00711
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Therapeutics USA Inc. et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2023cv00623
Plaintiff:
Horizon Therapeutics USA Inc. and Horizon Therapeutics Ireland DAC
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Counter Claimant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00410
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company v. Dr. Reddys Laboratories, Ltd. et al
as 1:2022cv01355
Plaintiff:
Eli Lilly and Company
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv01102
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Dr. Reddys Laboratories Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Inc. et al
as 1:2022cv00498
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv00298
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2021cv01349
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
